This project uses magnetic resonance imaging (MRI) to investigate the long-term consequences and potential brain toxicity resulting from use of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA), also known as Ecstasy, in human subjects. Evidence from animal studies indicates that MDMA destroys fine-diameter serotonergic axons that arise from brainstem serotonergic neuron groups. Serotonin is important in a wide variety of brain functions including mood, memory, movement, eating, sleeping, pain, and sexual function. Studies examining neuropsychiatric function in MDMA users have shown that MDMA users have impaired memory and may have greater levels of impulsivity. Other studies examining brain structure and function in MDMA users have suggested that use of MDMA damages the serotonin system in humans, much like it does in animal models. Our goals are to determine whether or not MDMA use is associated with structural and chemical brain changes that correlate with impaired brain function. We will use the functional MRI blood oxygen level dependent (BOLD) method to study brain function in two domains: visual system activation to red and blue light (as a sensory modality) and frontal and temporal brain activation during a semantic word learning and recall task (as a cognitive modality). We hypothesize that MDMA users will have reduced brain activation in the visual cortex to red and blue light stimulation. We hypothesize that MDMA users will show decreased activation in left Brodmann's Areas (BA) 45 and 21 during the word-learning and recall task. Because axon death can result in gliosis, we hypothesize that MDMA users will have higher levels of myoinositol (MI), (a chemical that may serve as a marker for gila) in a magnetic resonance spectroscopy (MRS) study. Because neurons contain the neuronal marker N-acetylaspartate (NAA), we hypothesize that NAA will be decreased in MDMA users due to loss of serotoninlinked growth factor production, resulting in smaller neurons. We will also use the voxel-based-morphometry (VBM) method to determine whether MDMA users have areas of reduced gray matter concentration and volume. We hypothesize that MDMA users will have areas of reduced gray matter concentration and volume that will correlate with areas of reduced activation in the fMRI studies and altered metabolite concentrations in the MRS studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA015137-02
Application #
6937779
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Nemeth-Coslett, Rosemarie V
Project Start
2004-08-15
Project End
2007-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
2
Fiscal Year
2005
Total Cost
$377,500
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Psychiatry
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Weinstein, Jodi J; Rogers, Baxter P; Taylor, Warren D et al. (2015) Effects of acute tryptophan depletion on raphé functional connectivity in depression. Psychiatry Res 234:164-71
Blackford, Jennifer Urbano; Clauss, Jacqueline A; Avery, Suzanne N et al. (2014) Amygdala-cingulate intrinsic connectivity is associated with degree of social inhibition. Biol Psychol 99:15-25
Charboneau, Evonne J; Dietrich, Mary S; Park, Sohee et al. (2013) Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results. Psychiatry Res 214:122-31
Watkins, Tristan J; Raj, Vidya; Lee, Junghee et al. (2013) Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing. Psychopharmacology (Berl) 227:41-54
Blackford, Jennifer Urbano; Allen, Amil H; Cowan, Ronald L et al. (2013) Amygdala and hippocampus fail to habituate to faces in individuals with an inhibited temperament. Soc Cogn Affect Neurosci 8:143-50
Benningfield, Margaret M; Cowan, Ronald L (2013) Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity. Neuropsychopharmacology 38:253-5
Di Iorio, Christina R; Watkins, Tristan J; Dietrich, Mary S et al. (2012) Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch Gen Psychiatry 69:399-409
Salomon, Ronald M; Karageorgiou, John; Dietrich, Mary S et al. (2012) MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity. Drug Alcohol Depend 120:41-7
Blackford, Jennifer Urbano; Avery, Suzanne N; Cowan, Ronald L et al. (2011) Sustained amygdala response to both novel and newly familiar faces characterizes inhibited temperament. Soc Cogn Affect Neurosci 6:621-9
Clauss, Jacqueline A; Cowan, Ronald L; Blackford, Jennifer Urbano (2011) Expectation and temperament moderate amygdala and dorsal anterior cingulate cortex responses to fear faces. Cogn Affect Behav Neurosci 11:13-21

Showing the most recent 10 out of 17 publications